EANM launches new award to accelerate alpha radioligand therapy research

The European Association of Nuclear Medicine (EANM) invites applications from early-career nuclear medicine researchers working on prostate cancer. Winners will be announced at the EANM’26 Congress.

2026-02-23

(Press-News.org) [Vienna, 23 February, 2026] — Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative research in alpha radioligand therapy (α-RLT) in prostate cancer. Winners will be recognised across three award categories: Platinum (40,000 euros), Gold (20,000 euros), and Silver (10,000 euros) awards.

“Alpha radioligand therapy is rapidly emerging as a transformative frontier in precision oncology, and we strongly believe in the talent of researchers at the beginning of their careers in this field,” says EANM President Paola Anna Erba. “This award was designed to nurture their growth by pairing research excellence with structured training, mentorship, and collaborative networking opportunities.”

Shaping the Future of Prostate Cancer

EANM invites applications from early career researchers — PhD candidates, postdoctoral fellows, junior faculty, and clinicians-in-training — who are within 10 years of their terminal degree and affiliated with an institution in an EANM member country.

Applicants must submit a project proposal aimed at offering clinically meaningful advances to prostate cancer treatment with the use of α-RLT. Priority areas include optimising clinical use, tailoring the treatment to individual patients, and identifying patients who might benefit the most from it. The deadline for application is May 18, 2026, at 23:59 CEST via ysn@eanm.org.

EANM’26 Congress

Winners will be announced at EANM’26 Congress, held from October 17 to 21 at the Austria Center Vienna (Austria). A dedicated session will give awardees the opportunity to present their projects to an open audience. In addition, they will participate in an interactive workshop with the scientific review committee to further develop their project proposals.

Full information on eligibility and how to apply is available here.

About EANM

EANM is the largest non-profit medical organisation dedicated to nuclear medicine in Europe. It provides a platform to discuss the latest developments in the field. EANM brings together nuclear medicine physicians, medical physicists, radiochemists, pharmacists, technologists, and experts from related fields. EANM works closely with 40 national societies, 20 non-European affiliated societies and international bodies to bring nuclear medicine to the forefront. Each year, the EANM Annual Congress welcomes nuclear medicine professionals from around the world—with a record attendance of more than 9,400 participants in 2025. The next EANM’26 congress will be held in Vienna (Austria) on October 17-21, 2026. In addition, EANM organises other scientific events every year to foster knowledge exchange. In August 2025, EANM also established its own two open-access journals, published as online-only by the world-leading publisher Elsevier.

END

ELSE PRESS RELEASES FROM THIS DATE:

Globe-trotting ancient ‘sea-salamander’ fossils rediscovered from Australia’s dawn of the Age of Dinosaurs

2026-02-23

Around 250 million years ago, what is today scorching desert in remote northwestern Australia was the shore of a shallow bay bordering a vast prehistoric ocean. Fossils recovered from this region over 60 years ago, and almost forgotten in museum collections, have now shed new light on the earliest global radiations of land-living animals adapting to life in the sea. The cataclysmic end-Permian mass extinction and extreme global warming prompted the emergence of modern marine ecosystems at the beginning of the Age of Dinosaurs (or Mesozoic era), some 252 ...

Roadmap for Europe’s biodiversity monitoring system

2026-02-23

Biodiversity is changing across the planet, yet governments still lack the robust, consistent data needed to track these changes and guide effective conservation. Now, a new study led by the University of Amsterdam (UvA), the German Centre for Integrative Biodiversity Research (iDiv), and the Martin Luther University Halle-Wittenberg (MLU), proposes a comprehensive roadmap to build a modern, integrated Biodiversity Observation Network (BON) for Europe – one that could become a global model for biodiversity monitoring in the ...

Novel camel antimicrobial peptides show promise against drug-resistant bacteria

2026-02-22

February 16, 2026—Antimicrobial resistance poses a growing global health crisis, with few new antibiotics in development. Researchers at Sultan Qaboos University have identified three novel antimicrobial peptides (AMPs) from dromedary camels that effectively target multidrug-resistant bacteria, offering potential alternatives to conventional drugs. Published in Frontiers in Immunology (Volume 17, 21 January 2026), the study combined bioinformatics predictions with experimental validation, including colony-forming assays, membrane permeability tests, and electron microscopy ...

Scientists discover why we know when to stop scratching an itch

2026-02-21

BETHESDA, MD – When you scratch an itch, something tells your brain when to stop. That moment of relief, when scratching feels “enough,” is not accidental. Scientists have now identified a key molecular and neural mechanism behind this built-in braking system, shedding new light on how the body regulates itch and why this control fails in chronic conditions. The research will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026. In a new study from the laboratory of Roberta Gualdani, professor at the University of ...

A hidden reason inner ear cells die – and what it means for preventing hearing loss

2026-02-21

BETHESDA, MD – Proteins long known to be essential for hearing have been hiding a talent: they also act as gatekeepers that shuffle fatty molecules across cell membranes. When this newly discovered function goes haywire—due to genetic mutations, noise-induced damage, or certain medications—it may be what kills the delicate sensory cells in our ears, causing permanent hearing loss. The research will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026. Deep inside our ears, specialized ...

Researchers discover how tuberculosis bacteria use a “stealth” mechanism to evade the immune system

2026-02-21

BETHESDA, MD – Scientists have uncovered an elegant biophysical trick that tuberculosis-causing bacteria use to survive inside human cells, a discovery that could lead to new strategies for fighting one of the world's deadliest infectious diseases. Tuberculosis kills more than a million people each year and remains a major public health crisis, particularly in Asia, Africa and Latin America. The disease is caused by mycobacteria, which have evolved sophisticated ways to hijack human immune cells ...

New microscopy technique lets scientists see cells in unprecedented detail and color

2026-02-21

BETHESDA, MD – Scientists have developed a new imaging technique that uses a novel contrast mechanism in bioimaging to merge the strengths of two powerful microscopy methods, allowing researchers to see both the intricate architecture of cells and the specific locations of proteins—all in vivid color and at nanometer resolution. The breakthrough, called multicolor electron microscopy, addresses a longstanding challenge in biological imaging: scientists have traditionally had to choose between seeing fine ...

Sometimes less is more: Scientists rethink how to pack medicine into tiny delivery capsules

2026-02-21

BETHESDA, MD – The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they’re a little disorganized. That’s the surprising finding from researchers who developed a new way to examine these drug-delivery vehicles one particle at a time—revealing that cramming in more medicine doesn't always mean better results. The research will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026. Lipid nanoparticles, or LNPs, are microscopic bubbles of fat that can ...

Scientists build low-cost microscope to study living cells in zero gravity

2026-02-21

BETHESDA, MD – As space agencies prepare for human missions to the Moon and Mars, scientists need to understand how the absence of gravity affects living cells. Now, a team of researchers has built a rugged, affordable microscope that can image cells in real time during the chaotic conditions of zero-gravity flight—and they’re making the design available to the broader scientific community. The research, previously published in npj Microgravity, will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026. “We know that astronauts’ cellular ...

The Biophysical Journal names Denis V. Titov the 2025 Paper of the Year-Early Career Investigator awardee

2026-02-21

BETHESDA, MD – Denis V. Titov, of the University of California, Berkeley, USA will be honored as the recipient of the Biophysical Journal Paper of the Year-Early Career Investigator Award at the 70th Annual Meeting of the Biophysical Society, held February 21-25 in San Francisco, California. This award recognizes the work of outstanding early career investigators in biophysics. The winning paper is titled “Glycolysis Model Shows that Allostery Maintains High ATP and Limits Accumulation of Intermediates.” The paper was published in Volume 124, Issue 10 of Biophysical Journal. Glycolysis ...

LAST 30 PRESS RELEASES:

Does mental health affect mortality risk in adults with cancer?